The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments.
Mariko KawamuraYutaro KoideTaro MuraiShunichi IshiharaYuuki TakaseTakayuki MuraoDai OkazakiTakahiro YamaguchiKaoru UchiyamaYoshiyuki ItohTakeshi KodairaYuta ShibamotoMika MizunoFumitaka KikkawaShinji NaganawaPublished in: BMC cancer (2021)
Our results suggest that the application of an SCCC regimen such as EP or IP as first-line chemotherapy for patients with locally advanced SCCC may play a key role in OS. These findings need to be validated in future nationwide, prospective clinical studies.